Mbwana J, Viscidi R, Lyamuya E, Mhalu F, Chalamilla G, Liljeqvist J-A, Lagergård T
Institute of Biomedicine, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.
Sex Transm Infect. 2007 Feb;83(1):64-5. doi: 10.1136/sti.2006.021279. Epub 2006 Jun 28.
The epidemiology of human papillomavirus (HPV) in Tanzania is largely unknown both in risk groups and in the general population.
To determine the cumulative seroprevalence of selected HPV types in order to evaluate exposure to HPV in urban Tanzania.
In a cross-sectional study, sera of 200 patients of both sexes with genital ulcer disease (GUD) and sera of 60 male blood donors and 60 pregnant women were tested for antibodies to the oncogenic HPV types 16, 18, 31, 33, 35, 51 and 52 using an ELISA based on virus-like particles (VLP).
The overall seroprevalence of HPV types for all patients with GUD was 83% and 77% for women and men, respectively. For pregnant women and male blood donors, the corresponding percentages were 55% and 15%, respectively. The most common HPV types were 16, 18 and 52. Infection with multiple types was more than 10 and 5 times more frequent than infection with a single type 16 in patients with GUD and in pregnant women, respectively. The seroprevalence to HPV types 16, 18, 51 and 52 was considerably higher in HIV-positive patients with GUD than in HIV-negative patients.
Infections with the oncogenic HPV types 16, 18 and 52 are common among patients with GUD and pregnant women in urban Tanzania, emphasising the need for control, treatment and implementation of appropriate HPV vaccine programmes.
坦桑尼亚人类乳头瘤病毒(HPV)在高危人群和普通人群中的流行病学情况在很大程度上尚不明确。
确定特定HPV类型的累积血清阳性率,以评估坦桑尼亚城市地区HPV的暴露情况。
在一项横断面研究中,采用基于病毒样颗粒(VLP)的酶联免疫吸附测定法(ELISA),对200例患有生殖器溃疡疾病(GUD)的男女患者的血清、60名男性献血者的血清以及60名孕妇的血清进行检测,以检测针对致癌性HPV 16、18、31、33、35、51和52型的抗体。
所有GUD患者中HPV各型的总体血清阳性率,女性为83%,男性为77%。孕妇和男性献血者的相应百分比分别为55%和15%。最常见的HPV类型为16、18和52型。在GUD患者和孕妇中,感染多种类型HPV的频率分别比单独感染16型HPV的频率高10倍和5倍以上。GUD患者中HIV阳性者针对HPV 16、18、51和52型的血清阳性率显著高于HIV阴性者。
在坦桑尼亚城市地区,致癌性HPV 16、18和52型感染在GUD患者和孕妇中很常见,这凸显了控制、治疗以及实施适当HPV疫苗计划的必要性。